ArticlePostepy dermatologii i alergologii2026
Pigmentation-dependent expression of pheomelanogenesis-related genes in human melanoma cells.
Article in Postepy dermatologii i alergologii, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Melanin synthesis is regulated by a complex genetic network, and its dysregulation can promote malignant transformation. Pheomelanin, a lighter and more photoreactive form of melanin, contributes to oxidative stress and may facilitate melanoma development. Its abundance varies with skin phototype, but its role in melanoma cell biology remains poorly characterized, highlighting the need to study pheomelanogenic gene expression in cells with distinct pigmentary. Aim: To address this, we analysed the expression of 44 genes related to melanocyte development and pigmentation, focusing on those directly or indirectly involved in pheomelanogenesis. Moreover, the melanin content in the examined cell lines was estimated. Material and methods: The study was conducted in two human melanoma cell lines that display contrasting pigmentation, amelanotic C32 and melanotic G361, using real-time RT-PCR to quantify gene expression levels. The melanin content in both cell lines was evaluated using Py-GC/MS/MS. Results: The content of melanin markers, normalised to one million cells, was 62% lower in amelanotic C32 cells than in melanotic G361 cells. Within the total isolated melanin pool, pheomelanin accounted for 0.52% in the C32 line and 0.78% in the G361 line. Melanoma cell lines with divergent melanin content also exhibited distinct gene-expression profiles: G361 cells showed higher expression of Conclusions: These findings indicate that variation in melanin content is closely linked to molecular heterogeneity in melanoma, underscoring the contribution of pheomelanin-related pathways to divergent melanoma phenotypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.